Applied Biosystems to Acquire the Research Products Division of Ambion, Inc.
29 Dec 2005 -
Applied Biosystems Group, an Applera Corporation business, and Ambion, Inc. announced they have signed a definitive agreement whereby Applied Biosystems will acquire the Research Products Division of Ambion, a premium supplier of RNA-based reagents for life science research and drug development, for approximately $273 million in cash. The transaction is subject to regulatory and other customary closing
conditions and is expected to close in the first calendar quarter of 2006.
Top
Print version
PDF version
Send article
RSS-Feed
